Market revenue in 2022 | USD 603.5 million |
Market revenue in 2030 | USD 2,226.1 million |
Growth rate | 17.7% (CAGR from 2022 to 2030) |
Largest segment | Master cell banking |
Fastest growing segment | Working Cell Banking |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Master Cell Banking, Working Cell Banking, Viral Cell Banking |
Key market players worldwide | Sartorius Stedim Biotech SA, BSL-BIOSERVICE Scientific Laboratories GmbH, Cryo-Cell International Inc, Charles River Laboratories International Inc, LifeCell International, Lonza Group Ltd, SGS AG, NAMSA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell banking outsourcing market will help companies and investors design strategic landscapes.
Master cell banking was the largest segment with a revenue share of 64.49% in 2022. Horizon Databook has segmented the Japan cell banking outsourcing market based on master cell banking, working cell banking, viral cell banking covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan cell banking outsourcing market, including forecasts for subscribers. This country databook contains high-level insights into Japan cell banking outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account